187 related articles for article (PubMed ID: 19910639)
1. Genetic association and interaction analysis of USF1 and APOA5 on lipid levels and atherosclerosis.
Laurila PP; Naukkarinen J; Kristiansson K; Ripatti S; Kauttu T; Silander K; Salomaa V; Perola M; Karhunen PJ; Barter PJ; Ehnholm C; Peltonen L
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):346-52. PubMed ID: 19910639
[TBL] [Abstract][Full Text] [Related]
2. Association of USF1 and APOA5 polymorphisms with familial combined hyperlipidemia in an Italian population.
Di Taranto MD; Staiano A; D'Agostino MN; D'Angelo A; Bloise E; Morgante A; Marotta G; Gentile M; Rubba P; Fortunato G
Mol Cell Probes; 2015 Feb; 29(1):19-24. PubMed ID: 25308402
[TBL] [Abstract][Full Text] [Related]
3. Association analysis of allelic variants of USF1 in coronary atherosclerosis.
Kristiansson K; Ilveskoski E; Lehtimäki T; Peltonen L; Perola M; Karhunen PJ
Arterioscler Thromb Vasc Biol; 2008 May; 28(5):983-9. PubMed ID: 18276913
[TBL] [Abstract][Full Text] [Related]
4. Upstream Transcription Factor 1 (USF1) allelic variants regulate lipoprotein metabolism in women and USF1 expression in atherosclerotic plaque.
Fan YM; Hernesniemi J; Oksala N; Levula M; Raitoharju E; Collings A; Hutri-Kähönen N; Juonala M; Marniemi J; Lyytikäinen LP; Seppälä I; Mennander A; Tarkka M; Kangas AJ; Soininen P; Salenius JP; Klopp N; Illig T; Laitinen T; Ala-Korpela M; Laaksonen R; Viikari J; Kähönen M; Raitakari OT; Lehtimäki T
Sci Rep; 2014 Apr; 4():4650. PubMed ID: 24722012
[TBL] [Abstract][Full Text] [Related]
5. APOA5 variants predispose hyperlipidemic patients to atherogenic dyslipidemia and subclinical atherosclerosis.
Guardiola M; Cofán M; de Castro-Oros I; Cenarro A; Plana N; Talmud PJ; Masana L; Ros E; Civeira F; Ribalta J
Atherosclerosis; 2015 May; 240(1):98-104. PubMed ID: 25770687
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein A5-1131T>C polymorphism, but not APOE genotypes, increases susceptibility for dyslipidemia in children and adolescents.
Brito DD; Fernandes AP; Gomes KB; Coelho FF; Cruz NG; Sabino AP; Cardoso JE; Figueiredo-Filho PP; Diamante R; Norton CR; Sousa MO
Mol Biol Rep; 2011 Oct; 38(7):4381-8. PubMed ID: 21132386
[TBL] [Abstract][Full Text] [Related]
7. Gene-gene interaction between APOA5 and USF1: two candidate genes for the metabolic syndrome.
Singmann P; Baumert J; Herder C; Meisinger C; Holzapfel C; Klopp N; Wichmann HE; Klingenspor M; Rathmann W; Illig T; Grallert H
Obes Facts; 2009; 2(4):235-42. PubMed ID: 20054229
[TBL] [Abstract][Full Text] [Related]
8. USF1 contributes to high serum lipid levels in Dutch FCHL families and U.S. whites with coronary artery disease.
Lee JC; Weissglas-Volkov D; Kyttälä M; Sinsheimer JS; Jokiaho A; de Bruin TW; Lusis AJ; Brennan ML; van Greevenbroek MM; van der Kallen CJ; Hazen SL; Pajukanta P
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2222-7. PubMed ID: 17673701
[TBL] [Abstract][Full Text] [Related]
9. APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease.
Lee KW; Ayyobi AF; Frohlich JJ; Hill JS
Atherosclerosis; 2004 Sep; 176(1):165-72. PubMed ID: 15306190
[TBL] [Abstract][Full Text] [Related]
10. USF1 gene variants, cardiovascular risk, and mortality in European Americans: analysis of two US cohort studies.
Reiner AP; Carlson CS; Jenny NS; Durda JP; Siscovick DS; Nickerson DA; Tracy RP
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2736-42. PubMed ID: 17885212
[TBL] [Abstract][Full Text] [Related]
11. Plasma fasting and nonfasting triglycerides and high-density lipoprotein cholesterol in atherosclerotic stroke: different profiles according to low-density lipoprotein cholesterol.
Kim SJ; Park YG; Kim JH; Han YK; Cho HK; Bang OY
Atherosclerosis; 2012 Aug; 223(2):463-7. PubMed ID: 22683121
[TBL] [Abstract][Full Text] [Related]
12. Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy.
Arnedo M; Taffé P; Sahli R; Furrer H; Hirschel B; Elzi L; Weber R; Vernazza P; Bernasconi E; Darioli R; Bergmann S; Beckmann JS; Telenti A; Tarr PE;
Pharmacogenet Genomics; 2007 Sep; 17(9):755-64. PubMed ID: 17700364
[TBL] [Abstract][Full Text] [Related]
13. The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease.
Jang Y; Paik JK; Hyun YJ; Chae JS; Kim JY; Choi JR; Lee SH; Shin DJ; Ordovas JM; Lee JH
Clin Chim Acta; 2009 Apr; 402(1-2):83-7. PubMed ID: 19159622
[TBL] [Abstract][Full Text] [Related]
14. Variants in the APOA5 gene region and the response to combination therapy with statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia.
Brautbar A; Covarrubias D; Belmont J; Lara-Garduno F; Virani SS; Jones PH; Leal SM; Ballantyne CM
Atherosclerosis; 2011 Dec; 219(2):737-42. PubMed ID: 21889769
[TBL] [Abstract][Full Text] [Related]
15. Interaction of dietary fat intake with APOA2, APOA5 and LEPR polymorphisms and its relationship with obesity and dyslipidemia in young subjects.
Domínguez-Reyes T; Astudillo-López CC; Salgado-Goytia L; Muñoz-Valle JF; Salgado-Bernabé AB; Guzmán-Guzmán IP; Castro-Alarcón N; Moreno-Godínez ME; Parra-Rojas I
Lipids Health Dis; 2015 Sep; 14():106. PubMed ID: 26365669
[TBL] [Abstract][Full Text] [Related]
16. The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study.
Martinelli N; Trabetti E; Bassi A; Girelli D; Friso S; Pizzolo F; Sandri M; Malerba G; Pignatti PF; Corrocher R; Olivieri O
Atherosclerosis; 2007 Apr; 191(2):409-17. PubMed ID: 16682041
[TBL] [Abstract][Full Text] [Related]
17. Triglyceride-raising APOA5 genetic variants are associated with obesity and non-HDL-C in Chinese children and adolescents.
Zhu WF; Wang CL; Liang L; Shen Z; Fu JF; Liu PN; Lv LQ; Zhu YM
Lipids Health Dis; 2014 Jun; 13():93. PubMed ID: 24903888
[TBL] [Abstract][Full Text] [Related]
18. Association of genetic variants influencing lipid levels with coronary artery disease in Japanese individuals.
Takeuchi F; Isono M; Katsuya T; Yokota M; Yamamoto K; Nabika T; Shimokawa K; Nakashima E; Sugiyama T; Rakugi H; Yamaguchi S; Ogihara T; Yamori Y; Kato N
PLoS One; 2012; 7(9):e46385. PubMed ID: 23050023
[TBL] [Abstract][Full Text] [Related]
19. Interaction of polymorphisms in APOA4-APOA5-ZPR1-BUD13 gene cluster and sleep duration on 5-year lipid changes in middle aged and older Chinese.
Yang L; Ma L; Guo W; Fang Q; Lai X; Zhang X
Sleep; 2019 Aug; 42(8):. PubMed ID: 31181149
[TBL] [Abstract][Full Text] [Related]
20. The Arg282Ser missense mutation in APOA5 gene determines a reduction of triglyceride and LDL-cholesterol in children, together with low serum levels of apolipoprotein A-V.
Bertoccini L; Sentinelli F; Incani M; Bailetti D; Cimini FA; Barchetta I; Cavallo MG; Cossu E; Lenzi A; Loche S; Baroni MG
Lipids Health Dis; 2017 Sep; 16(1):179. PubMed ID: 28927406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
